Medinotec Return on Equity (ROE) Growth & History (MDNC)

Medinotec's return on equity was 15.92% for fiscal 2026.

View full Medinotec company overview

Medinotec annual return on equity history

Medinotec annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20262026-02-2815.92%−51.17 pp
20252025-02-2867.09%+84.22 pp
20242024-02-29−17.14%+16.68 pp
20232023-02-28−33.82%

Medinotec return on equity trends

Between the periods ended 2023-02-28 and 2026-02-28, Medinotec's return on equity increased from −33.82% to 15.92%, a change of +49.74 percentage points. The latest reported quarter, Q1 2027, shows 3.84%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Medinotec source filings ↗

Community posts

It’s quiet here.

No posts about MDNC yet. Start the conversation.

Write the first post